In the past decades, several compounds have been tested in preclinical and clinical studies for their abilities to restore functional dystrophin levels in the muscle cells or to alter the fate of downstream molecular pathways involved in DMD pathophysiology. Here, DMD is linked to Duchenne muscular dystrophy.